Zydus Cadila partners with Eczacibasi to tap Turkish biosimilar market

The Ahmedabad-based Zydus Cadila yesterday signed a strategic collaboration agreement Eczacibasi Ilac Pazarlama AS, the Turkish healthcare company, to market biotech products in Turkey. The agreement involves the import of biosimilars which are currently unavailable in the country especially for the treatment of cancer and also paves the way for a long term strategic collaboration to produce and launch new products in the market.
 
Pankaj Patel, chairman and managing director of Zydus Group, stated, “We are glad to partner with Eczacibasi, a leading group in the field of healthcare in Turkey, to make available biotech therapies for patients in Turkey. The long term agreement between both partners to enrich this collaboration through introduction of new products, will augur well for healthcare access beyond geographies.”
   
Utilising its scientific and manufacturing expertise over the last many years, Zydus has built one of the largest biosimilars pipelines in India. The company currently markets 8 biosimilars products in India and has 20 biosimilars in various stages of development.